Kenya - engelsk - Pharmacy and Poisons Board

msn laboratories private limited msn house, plot no.c-24, industrial estate, - telmisartan - tablet - 80 mg - agents acting on the renin-angiotensin system:

Kenya - engelsk - Pharmacy and Poisons Board

msn laboratories private limited msn house, plot no.c-24, industrial estate, - telmisartan 80 mg and hydrochlorothiazide 12.5 mg… - capsule - telmisartan 80 mg and hydrochlorothiazide 12.5 mg… - agents acting on the renin-angiotensin system:

Kenya - engelsk - Pharmacy and Poisons Board

msn laboratories pvt ltd msn house plot no.: c – 24, sanath nagar - ticagrelor - film-coated tablet - 90mg - ticagrelor

Kenya - engelsk - Pharmacy and Poisons Board

msn laboratories private limited msn house”, plot no.: c-24, industrial - voriconazole - tablet - each tablet contains voriconazole ph. eur 200mg - antimycotics for systemic use: triazolederivatives

Kenya - engelsk - Pharmacy and Poisons Board

msn laboratories private limited msn house”, plot no.: c-24, industrial - voriconazole - tablet - 50mg - antimycotics for systemic use: triazolederivatives

USA - engelsk - NLM (National Library of Medicine)

msn laboratories private limited - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsules usp 250 mg is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsules usp 250 mg is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. trientine hydrochloride capsules usp 250 mg and penicillamine cannot be considered interchangeable. trientine hydrochloride capsules usp 250 mg should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsules usp 250 mg is not recommended in cystinuria or rheumatoid arthritis. the absence ofa sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsules usp 250 mg was reported not to be effective i

USA - engelsk - NLM (National Library of Medicine)

msn laboratories private limited - oseltamivir phosphate (unii: 4a3o49ngez) (oseltamivir acid - unii:k6106lv5q8) - oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated illness due to influenza a and b infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. oseltamivir phosphate capsules are indicated for the prophylaxis of influenza a and b in patients 1 year and older. - oseltamivir phosphate capsules  are not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices. - influenza viruses change over time. emergence of resistance substitutions could decrease drug effectiveness. other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate capsules [see microbiology (12.4)]. - oseltamivir phosphate capsules, are not reco

USA - engelsk - NLM (National Library of Medicine)

msn laboratories private limited - paclitaxel (unii: p88xt4is4d) (paclitaxel - unii:p88xt4is4d) - paclitaxel injection, usp is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. as first-line therapy, paclitaxel injection, usp is indicated in combination with cisplatin. paclitaxel injection, usp is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. in the clinical trial, there was an overall favorable effect on disease-free and overall survival in the total population of patients with receptor-positive and receptor-negative tumors, but the benefit has been specifically demonstrated by available data (median follow-up 30 months) only in the patients with estrogen and progesterone receptor-negative tumors ( see clinical studies: breast carcinoma ). paclitaxel injection, usp is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. prior therapy should hav

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: magnesium stearate; titanium dioxide; croscarmellose sodium; microcrystalline cellulose; methacrylic acid copolymer; colloidal anhydrous silica; triethyl citrate; methacrylic acid - ethyl acrylate copolymer (1:1); gelatin; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - dimethyl fumarate msn is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: purified talc; microcrystalline cellulose; gelatin; croscarmellose sodium; titanium dioxide; triethyl citrate; colloidal anhydrous silica; magnesium stearate; methacrylic acid copolymer; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - dimethyl fumarate msn is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.